Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Daniel Mullins

Showing results (81-90 of 333) with videos related to

Pageof 34
Sort By:
Pharmacoeconomics|September 14, 2010
Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trialsC Daniel Mullins, Danielle Whicher, Emily S Reese, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|April 8, 2015
Personalized Strategies to Activate and Empower Patients in Health Care and Reduce Health DisparitiesJie Chen, C Daniel Mullins, Priscilla Novak, et al.
The American Journal of Managed Care|August 22, 2002
Discontinuation rates of topical glaucoma medications in a managed care populationFadia T Shaya, C Daniel Mullins, Winston Wong, et al.
Cancer Detection and Prevention|February 24, 2006
Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictorsClaudia R Baquet, Patricia Commiskey, C Daniel Mullins, et al.
Cancer|September 19, 2002
Resources and use of the intensive care unit in patients who undergo surgery for ovarian carcinomaSandra E Brooks, Jeonghoon Ahn, C Daniel Mullins, et al.
Journal of Managed Care Pharmacy : JMCP|November 15, 2011
Developing a collaborative study protocol for combining payer-specific data and clinical trials for CERRobert J Sanchez, Jack Mardekian, Mark J Cziraky, et al.
Value in Health Regional Issues|September 6, 2020
Limitations and Challenges of Conducting Budget Impact Analyses in Rare Diseases: A Case Study of Alpha-1 Antitrypsin DeficiencyJuan-David Rueda, Jan Sieluk, Robert A Sandhaus, et al.
BMC Medical Research Methodology|January 4, 2014
Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancerEberechukwu Onukwugha, Candice Yong, Arif Hussain, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 26, 2014
Stakeholder engagement in patient-centered outcomes research: high-touch or high-tech?Danielle C Lavallee, Paul Wicks, Rafael Alfonso Cristancho, et al.
Clinical Therapeutics|January 19, 2008
Policy implications of drug importationFrancis B Palumbo, C Daniel Mullins, Ashley F Slagle, et al.
Pageof 34

Showing results (81-90 of 333) with videos related to

Sort By:
Pageof 34
Pharmacoeconomics|September 14, 2010
Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trialsC Daniel Mullins, Danielle Whicher, Emily S Reese, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|April 8, 2015
Personalized Strategies to Activate and Empower Patients in Health Care and Reduce Health DisparitiesJie Chen, C Daniel Mullins, Priscilla Novak, et al.
The American Journal of Managed Care|August 22, 2002
Discontinuation rates of topical glaucoma medications in a managed care populationFadia T Shaya, C Daniel Mullins, Winston Wong, et al.
Cancer Detection and Prevention|February 24, 2006
Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictorsClaudia R Baquet, Patricia Commiskey, C Daniel Mullins, et al.
Cancer|September 19, 2002
Resources and use of the intensive care unit in patients who undergo surgery for ovarian carcinomaSandra E Brooks, Jeonghoon Ahn, C Daniel Mullins, et al.
Journal of Managed Care Pharmacy : JMCP|November 15, 2011
Developing a collaborative study protocol for combining payer-specific data and clinical trials for CERRobert J Sanchez, Jack Mardekian, Mark J Cziraky, et al.
Value in Health Regional Issues|September 6, 2020
Limitations and Challenges of Conducting Budget Impact Analyses in Rare Diseases: A Case Study of Alpha-1 Antitrypsin DeficiencyJuan-David Rueda, Jan Sieluk, Robert A Sandhaus, et al.
BMC Medical Research Methodology|January 4, 2014
Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancerEberechukwu Onukwugha, Candice Yong, Arif Hussain, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 26, 2014
Stakeholder engagement in patient-centered outcomes research: high-touch or high-tech?Danielle C Lavallee, Paul Wicks, Rafael Alfonso Cristancho, et al.
Clinical Therapeutics|January 19, 2008
Policy implications of drug importationFrancis B Palumbo, C Daniel Mullins, Ashley F Slagle, et al.
Pageof 34